{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:59:58Z","timestamp":1760853598603,"version":"3.44.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.pbb.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T18:13:33Z","timestamp":1337278413000},"page":"329-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Depressive-like behavior in adrenocorticotropic hormone-treated rats blocked by memantine"],"prefix":"10.1016","volume":"102","author":[{"given":"Kenichi","family":"Tokita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2012.05.007_bb0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2005.11.023","article-title":"Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice","volume":"168","author":"Almeida","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.05.007_bb0010","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/archpsyc.1990.01810230054009","article-title":"Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims","volume":"47","author":"Arango","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1176\/ajp.146.6.730","article-title":"Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects","volume":"146","author":"Arora","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","article-title":"Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study","volume":"47","author":"Auer","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/S1516-44462008000300016","article-title":"Cerebellum and psychiatric disorders","volume":"30","author":"Baldacara","year":"2008","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.pbb.2012.05.007_bb0030","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1002\/pmic.200500069","article-title":"Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes","volume":"6","author":"Beasley","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.pbb.2012.05.007_bb0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145708009516","article-title":"Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response","volume":"12","author":"Block","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8.10A","key":"10.1016\/j.pbb.2012.05.007_bb0045","first-page":"1","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","volume":"55","author":"Castagne","year":"2011","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.pbb.2012.05.007_bb0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1152\/jn.00680.2002","article-title":"Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo","volume":"89","author":"Chen","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0055","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1073\/pnas.0507901102","article-title":"Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression","volume":"102","author":"Choudary","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2012.05.007_bb0060","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1590\/S0100-879X2011007500117","article-title":"Effects of chronic corticosterone and imipramine administration on panic and anxiety-related responses","volume":"44","author":"Diniz","year":"2011","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.pbb.2012.05.007_bb0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mehy.2009.10.051","article-title":"Magnesium for treatment-resistant depression: a review and hypothesis","volume":"74","author":"Eby","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pbb.2012.05.007_bb0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/depr.3050010307","article-title":"Reduction of cerebellar volume in major depression: a controlled MRI study","volume":"1","author":"Escalona","year":"1993","journal-title":"Depression"},{"key":"10.1016\/j.pbb.2012.05.007_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.schres.2003.08.014","article-title":"Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia","volume":"69","author":"Fatemi","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2012.05.007_bb0080","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/bmc.394","article-title":"Simultaneous determination of d- and l-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection","volume":"18","author":"Fukushima","year":"2004","journal-title":"Biomed Chromatogr"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2012.05.007_bb0085","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/01.psy.0000163456.22154.d2","article-title":"Hypercortisolemia and depression","volume":"67","author":"Gillespie","year":"2005","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pbb.2012.05.007_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pbb.2012.05.007_bb0095","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.pnpbp.2010.06.013","article-title":"The role of glutamate on the action of antidepressants","volume":"35","author":"Hashimoto","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-244X-5-6","article-title":"Elevated glutamine\/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients","volume":"5","author":"Hashimoto","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1573400054065569","article-title":"Dysfunction of glia\u2013neuron communication in pathophysiology of schizophrenia","volume":"1","author":"Hashimoto","year":"2005","journal-title":"Curr Psychiatry Rev"},{"key":"10.1016\/j.pbb.2012.05.007_bb0105","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neuint.2011.08.017","article-title":"Levels of d-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice","volume":"59","author":"Horio","year":"2011","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pbb.2012.05.007_bb0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0091-3057(87)90581-8","article-title":"Chronic imipramine effects on exploratory behavior in rats","volume":"27","author":"Hughes","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2012.05.007_bb0130","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuropharm.2011.05.015","article-title":"The effect of memantine in harmaline-induced tremor and neurodegeneration","volume":"61","author":"Iseri","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2012.05.007_bb0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S1461145708008985","article-title":"Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression","volume":"12","author":"Karolewicz","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.publhealth.29.020907.090847","article-title":"The descriptive epidemiology of commonly occurring mental disorders in the United States","volume":"29","author":"Kessler","year":"2008","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.pbb.2012.05.007_bb0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0091-3057(01)00625-6","article-title":"Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test","volume":"71","author":"Kitamura","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2012.05.007_bb0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1248\/bpb.31.246","article-title":"Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA","volume":"31","author":"Kitamura","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pbb.2012.05.007_bb0155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1139\/jpn.0526","article-title":"Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?","volume":"30","author":"Konarski","year":"2005","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pbb.2012.05.007_bb0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(97)01276-4","article-title":"Are Wistar\u2013Kyoto rats a genetic animal model of depression resistant to antidepressants?","volume":"337","author":"Lahmame","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"Suppl. 3","key":"10.1016\/j.pbb.2012.05.007_bb0165","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1016\/S0924-9338(05)80180-4","article-title":"The HPA and immune axes in stress: the involvement of the serotonergic system","volume":"20","author":"Leonard","year":"2005","journal-title":"Eur Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2012.05.007_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pscychresns.2011.05.009","article-title":"Structural deficits in the emotion circuit and cerebellum are associated with depression, anxiety and cognitive dysfunction in methadone maintenance patients: a voxel-based morphometric study","volume":"201","author":"Lin","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pbb.2012.05.007_bb0175","first-page":"167","article-title":"Treatment-resistant depression","volume":"80","author":"Little","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pbb.2012.05.007_bb0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pscychresns.2010.03.004","article-title":"Decreased regional homogeneity in insula and cerebellum: a resting-state fMRI study in patients with major depression and subjects at high risk for major depression","volume":"182","author":"Liu","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pbb.2012.05.007_bb0185","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1179\/136485906X97417","article-title":"Measuring the global burden of disease and epidemiological transitions: 2002\u20132030","volume":"100","author":"Lopez","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","article-title":"Ketamine and the next generation of antidepressants with a rapid onset of action","volume":"123","author":"Machado-Vieira","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2012.05.007_bb0205","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pneurobio.2009.03.003","article-title":"Two different putative genetic animal models of childhood depression\u2014a review","volume":"88","author":"Malkesman","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.04.023","article-title":"Reward and anxiety in genetic animal models of childhood depression","volume":"164","author":"Malkesman","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2012.05.007_bb0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopsych.2005.05.039","article-title":"Two different putative genetic animal models of childhood depression","volume":"59","author":"Malkesman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archpsyc.1986.01800100048007","article-title":"Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims","volume":"43","author":"Mann","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF00470589","article-title":"Effects of chlordiazepoxide and imipramine on maze patrolling within two different maze configurations by psychogenetically selected lines of rats","volume":"78","author":"Martin","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2012.05.007_bb0220","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tins.2006.06.008","article-title":"d-Serine signalling in the brain: friend and foe","volume":"29","author":"Martineau","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pbb.2012.05.007_bb0225","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1523\/JNEUROSCI.17-12-04886.1997","article-title":"Inhibition of stress-induced neuroendocrine and behavioral responses in the rat by prepro-thyrotropin-releasing hormone 178\u2013199","volume":"17","author":"McGivern","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2012.05.007_bb0230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S1516-44462003000400010","article-title":"Update on stress and depression: the role of the hypothalamic\u2013pituitary\u2013adrenal (HPA) axis","volume":"25","author":"Mello","year":"2003","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.pbb.2012.05.007_bb0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00403857","article-title":"Increases in spontaneous activity following intermittent imipramine administration","volume":"21","author":"Meltzer","year":"1971","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2012.05.007_bb0240","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2010.06.003","article-title":"Glial and glutamatergic markers in depression, alcoholism, and their comorbidity","volume":"127","author":"Miguel-Hidalgo","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pbb.2012.05.007_bb0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2230.2006.02128.x","article-title":"Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors","volume":"31","author":"Millington","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0250","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","article-title":"Correlation between plasma levels of glutamate, alanine and serine with severity of depression","volume":"30","author":"Mitani","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0255","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","article-title":"Potential antidepressive properties of amantadine, memantine and bifemelane","volume":"72","author":"Moryl","year":"1993","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0260","first-page":"713","article-title":"Zinc and depression. An update","volume":"57","author":"Nowak","year":"2005","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2012.05.007_bb0265","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1176\/appi.ajp.159.3.419","article-title":"Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims","volume":"159","author":"Pandey","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0270","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0306-4522(02)00364-0","article-title":"Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders","volume":"115","author":"Pardon","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2012.05.007_bb0275","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","article-title":"Glutamate and depression: clinical and preclinical studies","volume":"1003","author":"Paul","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pbb.2012.05.007_bb0280","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-3223(96)00335-6","article-title":"A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity","volume":"42","author":"Pillay","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0285","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1006815125689","article-title":"Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats","volume":"183","author":"Reddy","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pbb.2012.05.007_bb0295","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.brainresbull.2009.11.013","article-title":"Neurochemical and behavioural effects of acute and chronic memantine administration in rats: further support for NMDA as a new pharmacological target for the treatment of depression?","volume":"81","author":"Reus","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2012.05.007_bb0300","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rogoz","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2012.05.007_bb0305","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0310","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/14734220701490995","article-title":"The neuropsychiatry of the cerebellum \u2014 insights from the clinic","volume":"6","author":"Schmahmann","year":"2007","journal-title":"Cerebellum"},{"key":"10.1016\/j.pbb.2012.05.007_bb0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11530280-000000000-00000","article-title":"Therapeutic options for treatment-resistant depression","volume":"24","author":"Shelton","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2012.05.007_bb0320","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","article-title":"Glutamate-based antidepressants: 20years on","volume":"30","author":"Skolnick","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2012.05.007_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145703003900","article-title":"Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms","volume":"7","author":"Sumiyoshi","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in the human brain in depression and neurodegeneration","volume":"4","author":"Swaab","year":"2005","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.pbb.2012.05.007_bb0335","first-page":"588","article-title":"Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action","volume":"60","author":"Szewczyk","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2012.05.007_bb0340","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-3057(99)00261-0","article-title":"Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety","volume":"65","author":"Teixeira","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2012.05.007_bb0345","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0197-4580(92)90034-U","article-title":"Age-related reduction in pituitary corticotropin-releasing hormone receptors in two rat strains","volume":"13","author":"Tizabi","year":"1992","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pbb.2012.05.007_bb0350","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.pbb.2011.04.016","article-title":"Roles of glutamate signaling in preclinical and\/or mechanistic models of depression","volume":"100","author":"Tokita","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2012.05.007_bb0355","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bcp.2009.04.008","article-title":"Targeting glial physiology and glutamate cycling in the treatment of depression","volume":"78","author":"Valentine","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2012.05.007_bb0360","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.biopsych.2005.03.018","article-title":"Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels","volume":"57","author":"Yamada","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0365","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.pharmthera.2008.08.004","article-title":"Allosteric modulation of NMDA receptor via elevation of brain glycine and d-serine: the therapeutic potentials for schizophrenia","volume":"120","author":"Yang","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2012.05.007_bb0375","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2012.05.007_bb0370","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10673229.2010.511059","article-title":"Glutamatergic modulators: the future of treating mood disorders?","volume":"18","author":"Zarate","year":"2010","journal-title":"Harv Rev Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305712001426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305712001426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:31:20Z","timestamp":1758774680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305712001426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0091305712001426"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2012.05.007","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depressive-like behavior in adrenocorticotropic hormone-treated rats blocked by memantine","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2012.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}